Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-12-06 Purchase |
2021-12-07 6:44 pm |
CorMedix Inc. | CRMD | David Matthew T Interim CEO and CFO |
1,000 | $4.5 | $4,500 | 458,150 (Direct) |
View |
2021-12-06 Purchase |
2021-12-07 6:44 pm |
CorMedix Inc. | CRMD | David Matthew T Interim CEO and CFO |
1,000 | $4.5 | $4,500 | 458,150 (Direct) |
View |
2021-11-17 Purchase |
2021-11-19 09:53 am |
CorMedix Inc. | CRMD | David Matthew T Interim CEO and CFO |
1,000 | $5.07 | $5,070 | 457,150 (Direct) |
View |
2020-09-03 Purchase |
2020-09-08 08:38 am |
CorMedix Inc. | CRMD | David Matthew T Chief Financial Officer |
1,150 | $4.07 | $4,681 | 251,150 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-10 Tax Withholding |
2025-01-14 7:17 pm |
N/A N/A |
CorMedix Inc. | CRMD | David Matthew T Chief Financial Officer |
6,515 | $11.19 | 95,270 (Direct) |
View |
2025-01-02 Option Award |
2025-01-06 9:40 pm |
N/A N/A |
CorMedix Inc. | CRMD | David Matthew T Chief Financial Officer |
62,500 | $0 | 101,786 (Direct) |
View |
2025-01-02 Tax Withholding |
2025-01-06 9:40 pm |
N/A N/A |
CorMedix Inc. | CRMD | David Matthew T Chief Financial Officer |
8,648 | $8.22 | 101,786 (Direct) |
View |
2024-01-12 Option Award |
2024-01-17 8:10 pm |
N/A 2034-01-11 |
CorMedix Inc. | CRMD | David Matthew T Chief Financial Officer |
150,000 | $0 | 147,934 (Direct) |
View |
2024-01-12 Tax Withholding |
2024-01-17 8:10 pm |
N/A N/A |
CorMedix Inc. | CRMD | David Matthew T Chief Financial Officer |
5,216 | $3.47 | 147,934 (Direct) |
View |
2023-01-14 Option Award |
2023-01-18 6:53 pm |
N/A 2033-01-14 |
CorMedix Inc. | CRMD | David Matthew T Chief Financial Officer |
125,000 | $0 | 128,150 (Direct) |
View |
2022-02-18 Option Award |
2022-02-23 4:09 pm |
N/A 2032-02-18 |
CorMedix Inc. | CRMD | David Matthew T Interim CEO and CFO |
100,000 | $0 | 558,150 (Direct) |
View |
2021-11-01 Option Award |
2021-11-10 5:24 pm |
N/A 2031-11-01 |
CorMedix Inc. | CRMD | David Matthew T Interim CEO and CFO |
125,000 | $0 | 456,150 (Direct) |
View |
2021-01-11 Option Award |
2021-01-13 8:00 pm |
N/A 2031-01-11 |
CorMedix Inc. | CRMD | David Matthew T Chief Financial Officer |
80,000 | $0 | 331,150 (Direct) |
View |
2020-05-11 Option Award |
2020-05-13 4:18 pm |
N/A 2030-05-11 |
CorMedix Inc. | CRMD | David Matthew T EVP, Chief Financial Officer |
125,000 | $5.63 | 250,000 (Direct) |
View |
2020-05-11 Option Award |
2020-05-13 4:18 pm |
N/A 2030-05-11 |
CorMedix Inc. | CRMD | David Matthew T EVP, Chief Financial Officer |
125,000 | $4.08 | 250,000 (Direct) |
View |